Digital Diabetes Management Market Research Report- Forecast till 2027

Digital Diabetes Management Market: Information by Type (Wearable Devices, Handheld Devices), Product & Services (Devices, Digital Diabetes Management Apps, Services), End User (Homecare, Academic & Research Institutes)- Forecast till 2027

ID: MRFR/HC/6058-HCR | February 2021 | Region: Global | 85 pages

Digital Diabetes Management Market Scenario

The digital diabetes management market is accounted for USD 4,464.8 million in 2017 and expected to register ~ 23.7 % CAGR during the forecast period (2018–2023).

Digital diabetes management help diabetes patients to personalize and track diabetes by utilizing advanced paradigms of digital technologies through smart glucose meters and blood glucose tracking apps. Factor such as the rising prevalence of diabetes, increasing demand for self-care, technological advancements, rising geriatric population, and government initiative are expected to drive the growth of the market. Moreover, rising R&D spending and aggressive strategies adopted by the top players such as new product launches are contributing to the growth of the market. For instance, in October 2018, Novo Nordisk announced to introduce two connected insulin pens. However, the high cost associated with homecare devices and lack of awareness may hamper the growth of the digital diabetes management market during the assessment period.

Segmentation

The digital diabetes management market has been segmented on the basis of type, product and services, end user, and region.

On the basis of type, the market has been classified as wearable devices and handheld devices. The market, by product and service, has been segmented into devices, data management software and platforms, digital diabetes management apps, and services. The devices have been further segmented into smart glucose meters, smart insulin pens, continuous glucose monitoring systems, smart insulin pumps/closed loop systems & smart insulin patches. Moreover, digital diabetes management apps have been sub-segmented into weight & diet management apps and diabetes & blood glucose tracking apps. Based on end user, the market has been segmented into homecare, hospitals & specialty diabetes clinics, academic & research institutes, and others. The wearable devices segment is expected to hold the largest market share of the digital diabetes management market, by type, during the forecast period owing to regulatory approval of CGM system and technological advancement such as smart insulin patches. Also, homecare segment, by end user holds the largest market share in the digital diabetes management global market during the forecast period.

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The digital diabetes management market in the Americas has further been segmented into North America and South America. Whereas, North American region has been further divided into the US and Canada.

The European digital diabetes management market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the Rest of Western Europe. 

The digital diabetes management market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and Rest of Asia-Pacific. The digital diabetes management global market in the Middle East & Africa has been segmented into the Middle East and Africa.

Regional Market Summary

Digital Diabetes Management Global Market Share, by Region, 2017 (%)


Digital Diabetes Management Market


Source: MRFR Analysis


The Americas are likely to dominate the global digital diabetes management market owing to the wide acceptance of technologically advanced solutions such as closed-loop control systems, rising adoption of diabetes management remote online coaching services, connected diabetes management apps. Moreover, favorable reimbursement policies, raising awareness, government initiatives to promote digital health, and aggressive strategic adopted by players such as product launch, merger & acquisition, and partnership in this region also fueling the growth of digital diabetes management market. For instance, in November 2018, Nutrino has been acquired by Medtronic plc that strengthened Medtronic's portfolio in the digital diabetes management Industry.


The European market is expected to be the second-largest digital diabetes management market. The market growth in this region can be attributed to the government support for research & development and availability of funds for research.


Asia-Pacific is expected to be the fastest-growing digital diabetes management market during the forecast period owing to the rising number of the diabetes patient, increasing investments in healthcare and expansions by market players in the region. Moreover, countries such as India and China are considering the fastest growing region due to the presence of a huge patient population. Moreover, the government of these countries is open to adopting new technology and the best treatment option from a developed country. According to a research paper published by the National Center for Biotechnology Information (NCBI) in September 2016, diabetes will be the 7th leading cause of death by 2030.


The market in the Middle East & Africa is expected to account for the smallest share of the global digital diabetes management market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.


Key Players


Some of the key players in the global digital diabetes management market are



  • Abbott Laboratories

  • Agamatrix Inc.

  • Ascensia Diabetes Care Holdings Ag.

  • Braun Melsungen AG

  • Dariohealth Corporation

  • Dexcom Inc.

  • Hoffmann-La Roche

  • Glooko Inc.

  • Insulet Corporation

  • Lifescan Inc.

  • Medtronic PLC

  • Tandem Diabetes Care Inc.

  • Tidepool

  • Others


Global Digital Diabetes Management Market, by Type



  • Wearable Devices

  • Handheld Devices


Global Digital Diabetes Management Market, by Product and Service



  • DevicesSmart Glucose Meters

  • Smart Insulin Pens

  • Continuous Glucose Monitoring Systems

  • Smart Insulin Pumps/Closed Loop Systems & Smart Insulin Patches

  • Data Management Software and Platforms

  • Digital Diabetes Management AppsWeight & Diet Management Apps

  • Diabetes & Blood Glucose Tracking Apps

  • Services


Global Digital Diabetes Management Market, by End User



  • Homecare

  • Hospitals & Specialty Diabetes Clinics

  • Academic & Research Institutes

  • Others


Global Digital Diabetes Management Market, by Region



  • Americas

    • North America

      • US

      • Canada



    • South America



  • Europe

    • Western Europe

      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe



    • Eastern Europe



  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • The Middle East & Africa

    • Middle East

    • Africa




Intended Audience


  • Medical devices companies

  • Hospitals

  • Research and development (R&D) companies

  • Medical research laboratories

  • Research and consulting firms



Report Scope:
Report Attribute/Metric Details
  Market Size   2017: USD 4,464.8 million
  CAGR   2017-2023: 23.7 %
  Base Year   2019
  Forecast Period   2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type, Product and Service, End User And Region
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Abbott Laboratories, Agamatrix, Inc., Ascensia Diabetes Care Holdings Ag., B. Braun Melsungen AG, Dariohealth Corporation, Dexcom, Inc., F. Hoffmann-La Roche, Glooko, Inc., Insulet Corporation, Lifescan, Inc., Medtronic PLC, Tandem Diabetes Care, Inc., Tidepool, and others
  Key Market Opportunities   Adopting new technology and the best treatment option from a developed country
  Key Market Drivers   The growing prevalence of diabetes is the major driver for the market.


Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :

The Type of devices included in the Digital Diabetes Management Market are Wearable Devices, Handheld Devices.

The market is expected to exhibit a strong 23.7% CAGR over the forecast period from 2018 to 2023.

The growing prevalence of diabetes is the major driver for the market.

North America is the leading regional market, followed by Europe.

Leading players in the digital diabetes management market include B. Braun Melsungen, Abbott, F. Hoffman-La Roche, Agamatrix Inc., and Glooko, among others.

The global digital diabetes management market was valued at more than USD 4.4 billion in 2017.

Table of Contents:


Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

Chapter 3. Research Methodology

3.1. Introduction

3.2. Primary Research

3.3. Secondary Research

3.4. Market Size Estimation

Chapter 4. Market Dynamics

4.1. Drivers

4.2. Restraints

4.3. Opportunities

4.4. Challenges

4.5. Macroeconomic Indicators

4.6. Mega Trends & Assessment

Chapter 5. Market Factor Analysis

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

5.3. Investment Feasibility Analysis

5.4. Pricing Analysis

5.5. Regulatory Analysis

5.6. Reimbursement Scenario

Chapter 6. Global Digital Diabetes Management Market, by Type

6.1. Introduction

6.2. Wearable Devices

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3. Handheld Devices

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 7. Global Digital Diabetes Management Market, by Product and Service

7.1. Introduction

7.2. Devices

7.2.1. Smart Glucose Meters

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.2.2. Smart Insulin Pens

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.2.3. Continuous Glucose Monitoring Systems

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.2.4. Smart Insulin Pumps/Closed Loop Systems & Smart Insulin Patches

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3. Data Management Software and Platforms

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4. Digital Diabetes Management Apps

7.4.1. Weight & Diet Management Apps

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4.2. Diabetes & Blood Glucose Tracking Apps

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.5. Services

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 8. Global Digital Diabetes Management Market, by End User

8.1. Introduction

8.2. Homecare

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3. Hospitals & Specialty Diabetes Clinics

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4. Academic & Research Institutes

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.5. Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 9. Global Digital Diabetes Management Market, by Region

9.1. Introduction

9.2. Americas

9.2.1. North America

9.2.1.1. US

9.2.1.2. Canada

9.2.2. South America

9.3. Europe

9.3.1. Western Europe

9.3.1.1. Germany

9.3.1.2. France

9.3.1.3. Italy

9.3.1.4. Spain

9.3.1.5. UK

9.3.1.6. Rest of Western Europe

9.3.2. Eastern Europe

9.4. Asia-Pacific

9.4.1. Japan

9.4.2. China

9.4.3. India

9.4.4. Australia

9.4.5. South Korea

9.4.6. Rest of Asia-Pacific

9.5. Middle East & Africa

9.5.1. Middle East

9.5.2. Africa

Chapter 10. Company Landscape

10.1. Introduction

10.2. Market Share Analysis

10.3. Key Developments & Strategies

Chapter 11. Company Profiles

11.1. Abbott Laboratories

11.1.1. Company Overview

11.1.2. Product Overview

11.1.3. Financial Overview

11.1.4. Key Developments

11.1.5. SWOT Analysis

11.1.6. Key Strategies

11.2. Agamatrix, Inc.

11.2.1. Company Overview

11.2.2. Product Overview

11.2.3. Financial Overview

11.2.4. Key Developments

11.2.5. SWOT Analysis

11.2.6. Key Strategies

11.3. Ascensia Diabetes Care Holdings Ag.

11.3.1. Company Overview

11.3.2. Product Overview

11.3.3. Financial Overview

11.3.4. Key Developments

11.3.5. SWOT Analysis

11.3.6. Key Strategies

11.4. B. Braun Melsungen AG

11.4.1. Company Overview

11.4.2. Product Overview

11.4.3. Financial Overview

11.4.4. Key Developments

11.4.5. SWOT Analysis

11.4.6. Key Strategies

11.5. Dariohealth Corporation

11.5.1. Company Overview

11.5.2. Product Overview

11.5.3. Financial Overview

11.5.4. Key Developments

11.5.5. SWOT Analysis

11.5.6. Key Strategies

11.6. Dexcom, Inc.

11.6.1. Company Overview

11.6.2. Product Overview

11.6.3. Financial Overview

11.6.4. Key Developments

11.6.5. SWOT Analysis

11.6.6. Key Strategies

11.7. F. Hoffmann-La Roche

11.7.1. Company Overview

11.7.2. Product Overview

11.7.3. Financial Overview

11.7.4. Key Developments

11.7.5. SWOT Analysis

11.7.6. Key Strategies

11.8. Glooko, Inc.

11.8.1. Company Overview

11.8.2. Product Overview

11.8.3. Financial Overview

11.8.4. Key Developments

11.8.5. SWOT Analysis

11.8.6. Key Strategies

11.9. Insulet Corporation

11.9.1. Company Overview

11.9.2. Product Overview

11.9.3. Financial Overview

11.9.4. Key Developments

11.9.5. SWOT Analysis

11.9.6. Key Strategies

11.10. Lifescan, Inc. (A Subsidiary of Johnson & Johnson)

11.10.1. Company Overview

11.10.2. Product Overview

11.10.3. Financial Overview

11.10.4. Key Developments

11.10.5. SWOT Analysis

11.10.6. Key Strategies

11.11. Medtronic PLC

11.11.1. Company Overview

11.11.2. Product Overview

11.11.3. Financial Overview

11.11.4. Key Developments

11.11.5. SWOT Analysis

11.11.6. Key Strategies

11.12. Tandem Diabetes Care, Inc.

11.12.1. Company Overview

11.12.2. Product Overview

11.12.3. Financial Overview

11.12.4. Key Developments

11.12.5. SWOT Analysis

11.12.6. Key Strategies

11.13. Tidepool

11.13.1. Company Overview

11.13.2. Product Overview

11.13.3. Financial Overview

11.13.4. Key Developments

11.13.5. SWOT Analysis

11.13.6. Key Strategies

11.14. Others

Chapter 12. MRFR Conclusion

12.1. Key Findings

12.1.1. From CEO’s Viewpoint

12.1.2. Unmet Needs of the Market

12.2. Key Companies to Watch

12.3. Predictions for the Digital Diabetes Management Industry

Chapter 13. Appendix

 

LIST OF TABLES

Table 1. Global Digital Diabetes Management Market Synopsis, 2020-2027

Table 2. Global Digital Diabetes Management Market Estimates and Forecast, 2020-2027 (USD Million)

Table 3. Global Digital Diabetes Management Market, by Region, 2020-2027 (USD Million)

Table 4. Global Digital Diabetes Management Market, by Type, 2020-2027 (USD Million)

Table 5. Global Digital Diabetes Management Market, by Product & Services, 2020-2027 (USD Million)

Table 6. Global Digital Diabetes Management Market, by End User, 2020-2027 (USD Million)

Table 7. North America: Digital Diabetes Management Market, by Type, 2020-2027 (USD Million)

Table 8. North America: Digital Diabetes Management Market, by Product & Services, 2020-2027 (USD Million)

Table 9. North America: Digital Diabetes Management Market, by End User, 2020-2027 (USD Million)

Table 10. US: Digital Diabetes Management Market, by Type, 2020-2027 (USD Million)

Table 11. US: Digital Diabetes Management Market, by Product & Services, 2020-2027 (USD Million)

Table 12. US: Digital Diabetes Management Market, by End User, 2020-2027 (USD Million)

Table 13. Canada: Digital Diabetes Management Market, by Type, 2020-2027 (USD Million)

Table 14. Canada: Digital Diabetes Management Market, by Product & Services, 2020-2027 (USD Million)

Table 15. Canada: Digital Diabetes Management Market, by End User, 2020-2027 (USD Million)

Table 16. South America: Digital Diabetes Management Market, by Type, 2020-2027 (USD Million)

Table 17. South America: Digital Diabetes Management Market, by Product & Services, 2020-2027 (USD Million)

Table 18. South America: Digital Diabetes Management Market, by End User, 2020-2027 (USD Million)

Table 19. Europe: Digital Diabetes Management Market, by Type, 2020-2027 (USD Million)

Table 20. Europe: Digital Diabetes Management Market, by Product & Services, 2020-2027 (USD Million)

Table 21. Europe: Digital Diabetes Management Market, by End User, 2020-2027 (USD Million)

Table 22. Western Europe: Digital Diabetes Management Market, by Type, 2020-2027 (USD Million)

Table 23. Western Europe: Digital Diabetes Management Market, by Product & Services, 2020-2027 (USD Million)

Table 24. Western Europe: Digital Diabetes Management Market, by End User, 2020-2027 (USD Million)

Table 25. Eastern Europe: Digital Diabetes Management Market, by Type, 2020-2027 (USD Million)

Table 26. Eastern Europe: Digital Diabetes Management Market, by Product & Services, 2020-2027 (USD Million)

Table 27. Eastern Europe: Digital Diabetes Management Market, by End User, 2020-2027 (USD Million)

Table 28. Asia-Pacific: Digital Diabetes Management Market, by Type, 2020-2027 (USD Million)

Table 29. Asia-Pacific: Digital Diabetes Management Market, by Product & Services, 2020-2027 (USD Million)

Table 30. Asia-Pacific: Digital Diabetes Management Market, by End User, 2020-2027 (USD Million)

Table 31. Middle East & Africa: Digital Diabetes Management Market, by Type, 2020-2027 (USD Million)

Table 32. Middle East & Africa: Digital Diabetes Management Market, by Product & Services, 2020-2027 (USD Million)

Table 33. Middle East & Africa: Digital Diabetes Management Market, by End User, 2020-2027 (USD Million)

LIST OF FIGURES

Figure 1. Research Process

Figure 2. Segmentation for Global Digital Diabetes Management Market

Figure 3. Segmentation Market Dynamics for Global Digital Diabetes Management Market

Figure 4. Global Digital Diabetes Management Market Share, by Type, 2020

Figure 5. Global Digital Diabetes Management Market Share, by Product & Services, 2020

Figure 6. Global Digital Diabetes Management Market Share, by End User, 2020

Figure 7. Global Digital Diabetes Management Market Share, by Region, 2020

Figure 8. North America: Digital Diabetes Management Market Share, by Country, 2020

Figure 9. Europe: Digital Diabetes Management Market Share, by Country, 2020

Figure 10. Asia-Pacific: Digital Diabetes Management Market Share, by Country, 2020

Figure 11. Middle East & Africa: Digital Diabetes Management Market Share, by Country, 2020

Figure 12. Global Digital Diabetes Management Market: Company Share Analysis, 2020 (%)

Figure 13. Abbott Laboratories: Key Financials

Figure 14. Abbott Laboratories: Segmental Revenue

Figure 15. Abbott Laboratories: Geographical Revenue

Figure 16. Agamatrix, Inc.: Key Financials

Figure 17. Agamatrix, Inc.: Segmental Revenue

Figure 18. Agamatrix, Inc.: Geographical Revenue

Figure 19. Ascensia Diabetes Care Holdings Ag.: Key Financials

Figure 20. Ascensia Diabetes Care Holdings Ag.: Segmental Revenue

Figure 21. Ascensia Diabetes Care Holdings Ag.: Geographical Revenue

Figure 22. B. Braun Melsungen AG: Key Financials

Figure 23. B. Braun Melsungen AG: Segmental Revenue

Figure 24. B. Braun Melsungen AG: Geographical Revenue

Figure 25. Dariohealth Corporation: Key Financials

Figure 26. Dariohealth Corporation: Segmental Revenue

Figure 27. Dariohealth Corporation: Geographical Revenue

Figure 28. Dexcom, Inc.: Key Financials

Figure 29. Dexcom, Inc.: Segmental Revenue

Figure 30. Dexcom, Inc.: Geographical Revenue

Figure 31. F. Hoffmann-La Roche: Key Financials

Figure 32. F. Hoffmann-La Roche: Segmental Revenue

Figure 33. F. Hoffmann-La Roche: Geographical Revenue

Figure 34. Glooko, Inc.: Key Financials

Figure 35. Glooko, Inc.: Segmental Revenue

Figure 36. Glooko, Inc.: Geographical Revenue

Figure 37. Insulet Corporation: Key Financials

Figure 38. Insulet Corporation: Segmental Revenue

Figure 39. Insulet Corporation: Geographical Revenue

Figure 40. Lifescan, Inc.: Key Financials

Figure 41. Lifescan, Inc.: Segmental Revenue

Figure 42. Lifescan, Inc.: Geographical Revenue

Figure 43. Medtronic PLC: Key Financials

Figure 44. Medtronic PLC: Segmental Revenue

Figure 45. Medtronic PLC: Geographical Revenue

Figure 46. Tandem Diabetes Care, Inc.: Key Financials

Figure 47. Tandem Diabetes Care, Inc.: Segmental Revenue

Figure 48. Tandem Diabetes Care, Inc.: Geographical Revenue

Figure 49. Tidepool: Key Financials

Figure 50. Tidepool: Segmental Revenue

Figure 51. Tidepool: Geographical Revenue



This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.